Joben Bio-Medical Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 54.836 million compared to TWD 88.892 million a year ago. Operating loss was TWD 84.836 million compared to TWD 70.673 million a year ago. Net loss was TWD 67.692 million compared to TWD 53.771 million a year ago. Basic loss per share was TWD 1.11 compared to TWD 0.88 a year ago.